Literature DB >> 25091623

The anti-inflammatory effect of 3-deoxysappanchalcone is mediated by inducing heme oxygenase-1 via activating the AKT/mTOR pathway in murine macrophages.

Jun-Hyeong Kim1, Young-Yeon Choo1, Nara Tae1, Byung-Sun Min2, Jeong-Hyung Lee3.   

Abstract

3-Deoxysappanchalcone (3-DSC), isolated from Caesalpinia sappan (Leguminosae), is a chalcone that exerts a variety of pharmacological activities. In the present study, we demonstrated that 3-DSC exerts anti-inflammatory activity in murine macrophages by inducing heme oxygenase-1 (HO-1) expression at the translational level. Treatment of RAW264.7 cells with 3-DSC induced HO-1 protein expression in a dose- and time-dependent manner without affecting HO-1 mRNA expression. Mitogen-activated protein kinase inhibitors or actinomycin D, a transcriptional inhibitor, did not block 3-DSC-mediated HO-1 induction. However, 3-DSC-mediated HO-1 induction was completely blocked by treatment with cycloheximide, a translational inhibitor, or rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR). Strikingly, 3-DSC increased the phosphorylation level of mTOR downstream target molecules such as eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) and S6 kinase 1 (S6K1), as well as AKT in a dose- and time-dependent manner, suggesting that the 3-DSC induces HO-1 expression by activating the AKT/mTOR pathway. Consistent with the notion that HO-1 has anti-inflammatory properties, 3-DSC inhibited the production of nitric oxide (NO) and interleukin (IL)-6 in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Inhibition of HO-1 activity by treatment with tin protoporphyrin IX, a specific HO-1 inhibitor, abrogated the inhibitory effects of 3-DSC on the production of NO and IL-6 in LPS-stimulated RAW264.7 cells. Taken together, 3-DSC may be an effective HO-1 inducer at the translational level that has anti-inflammatory effects, and a valuable compound for modulating inflammatory conditions.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3-Deoxysappanchalcone; Anti-inflammatory effect; Heme oxygenase-1; Translation; mTOR

Mesh:

Substances:

Year:  2014        PMID: 25091623     DOI: 10.1016/j.intimp.2014.07.025

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  Involvement of Heme Oxygenase-1 in Orexin-A-induced Angiogenesis in Vascular Endothelial Cells.

Authors:  Mi-Kyoung Kim; Hyun-Joo Park; Su-Ryun Kim; Yoon Kyung Choi; Soo-Kyung Bae; Moon-Kyoung Bae
Journal:  Korean J Physiol Pharmacol       Date:  2015-06-30       Impact factor: 2.016

2.  3-Deoxysappanchalcone Promotes Proliferation of Human Hair Follicle Dermal Papilla Cells and Hair Growth in C57BL/6 Mice by Modulating WNT/β-Catenin and STAT Signaling.

Authors:  Young Eun Kim; Hyung Chul Choi; In-Chul Lee; Dong Yeon Yuk; Hyosung Lee; Bu Young Choi
Journal:  Biomol Ther (Seoul)       Date:  2016-11-01       Impact factor: 4.634

3.  Anti-Inflammatory Activity of Sanghuangporus sanghuang Mycelium.

Authors:  Wang-Ching Lin; Jeng-Shyan Deng; Shyh-Shyun Huang; Sheng-Hua Wu; Chin-Chu Chen; Wan-Rong Lin; Hui-Yi Lin; Guan-Jhong Huang
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923

4.  3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo.

Authors:  Xiaorong Fu; Ran Zhao; Goo Yoon; Jung-Hyun Shim; Bu Young Choi; Fanxiang Yin; Beibei Xu; Kyle Vaughn Laster; Kangdong Liu; Zigang Dong; Mee-Hyun Lee
Journal:  Front Cell Dev Biol       Date:  2021-03-25

5.  Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology.

Authors:  Xiaomin Kang; Yuqing Zhang; Rongrong Zhou; Yuehong Zhang; Fengmei Lian
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-29       Impact factor: 2.629

Review 6.  Modulation of Hair Growth Promoting Effect by Natural Products.

Authors:  Seyeon Park; Joomin Lee
Journal:  Pharmaceutics       Date:  2021-12-15       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.